Search Results - "Foeldvari, I."

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry by Horneff, G, De Bock, F, Foeldvari, I, Girschick, H J, Michels, H, Moebius, D, Schmeling, H

“…Etanercept monotherapy has been studied and approved for treatment of polyarticular juvenile idiopathic arthritis (JIA). The following study evaluates the…”
Get more information

Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry by Klein, A., Kaul, I., Foeldvari, I., Ganser, G., Urban, A., Horneff, G.

“…Objective The German Methotrexate Registry has been collecting data concerning the efficacy and safety of methotrexate (MTX) treatment since 2005. The aim of…”
Get full text

Temporomandibular joint involvement in patients with juvenile idiopathic arthritis: a retrospective chart review by von Schuckmann, L, Klotsche, J, Suling, A, Kahl-Nieke, B, Foeldvari, I

“…To study the proportion of patients with temporomandibular joint (TMJ) involvement among patients with juvenile idiopathic arthritis (JIA), as well as…”
Get full text

Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis by Heiligenhaus, A., Minden, K., Tappeiner, C., Baus, H., Bertram, B., Deuter, C., Foeldvari, I., Föll, D., Frosch, M., Ganser, G., Gaubitz, M., Günther, A., Heinz, C., Horneff, G., Huemer, C., Kopp, I., Lommatzsch, C., Lutz, T., Michels, H., Neß, T., Neudorf, U., Pleyer, U., Schneider, M., Schulze-Koops, H., Thurau, S., Zierhut, M., Lehmann, H.W.

“…Uveitis in juvenile idiopathic arthritis (JIAU) is frequently associated with the development of complications and visual loss. Topical corticosteroids are the…”
Get full text

Durometry as an outcome measure in juvenile localized scleroderma by Poff, S., Li, S.C., Kelsey, C.E., Foeldvari, I., Torok, K.S.

“…Plain language summary available online…”
Get full text

Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry by Raab, A, Kallinich, T, Huscher, D, Foeldvari, I, Weller-Heinemann, F, Dressler, F, Kuemmerle-Deschner, J B, Klein, A, Horneff, G

“…Oligoarticular juvenile idiopathic arthritis (oligoJIA) is the most commonly diagnosed category of chronic arthritis in children. Nevertheless, there are no…”
Get full text

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes by Knobler, R., Geroldinger‐Simić, M., Kreuter, A., Hunzelmann, N., Moinzadeh, P., Rongioletti, F., Denton, C. P., Mouthon, L., Cutolo, M., Smith, V., Gabrielli, A., Bagot, M., Olesen, A. B., Foeldvari, I., Jalili, A., Kähäri, V., Kárpáti, S., Kofoed, K., Olszewska, M., Panelius, J., Quaglino, P., Seneschal, J., Sticherling, M., Sunderkötter, C., Tanew, A., Wolf, P., Worm, M., Skrok, A., Rudnicka, L., Krieg, T.

“…The term ‘sclerosing diseases of the skin’ comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly…”
Get full text

Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry by Klein, A, Becker, I, Minden, K, Foeldvari, I, Haas, JP, Horneff, G

“…Objective: Adalimumab (ADA) has become a valuable treatment option for juvenile idiopathic arthritis (JIA). The importance of combination with methotrexate…”
Get full text

Skin involvement in systemic sclerosis by Czirják, L., Foeldvari, I., Müller-Ladner, U.

“…Skin thickening is a characteristic feature of SSc. More extensive skin involvement coincides with more severe internal organ manifestation(s), poor prognosis…”
Get full text

Systemic sclerosis in childhood by Foeldvari, I

“…Juvenile systemic sclerosis (jSSc) is a rare disease of childhood, and the amount of published data is limited. It appears that its clinical presentation…”
Get full text

Uveitis in juvenile idiopathic arthritis by Foeldvari, I, Walscheid, K, Heiligenhaus, A

“…Uveitis is the most common extra-articular manifestation of juvenile idiopathic arthritis (JIA). It occurs, according to German registry data, in around 12% of…”
Get full text

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension by Ruperto, Nicolino, Lovell, Daniel J, Cuttica, Ruben, Woo, Patricia, Meiorin, Silvia, Wouters, Carine, Silverman, Earl D, Balogh, Zsolt, Henrickson, Michael, Davidson, Joyce, Foeldvari, Ivan, Imundo, Lisa, Simonini, Gabriele, Oppermann, Joachim, Xu, Stephen, Shen, Yaung-Kaung, Visvanathan, Sudha, Fasanmade, Adedigbo, Mendelsohn, Alan, Martini, Alberto, Giannini, Edward H

“…To assess the long-term efficacy and safety of infliximab plus methotrexate in juvenile rheumatoid arthritis (JRA). Patients eligible for the open-label…”
Get more information

Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study by Zulian, F., Athreya, B. H., Laxer, R., Nelson, A. M., Feitosa de Oliveira, S. K., Punaro, M. G., Cuttica, R., Higgins, G. C., Van Suijlekom-Smit, L. W. A., Moore, T. L., Lindsley, C., Garcia-Consuegra, J., Esteves Hilário, M. O., Lepore, L., Silva, C. A, Machado, C., Garay, S. M., Uziel, Y., Martini, G., Foeldvari, I., Peserico, A., Woo, P., Harper, J.

“…Objective. Juvenile localized scleroderma (JLS) includes a number of conditions often grouped together. With the long-term goal of developing uniform…”
Get full text

Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis by Heiligenhaus, A., Michels, H., Schumacher, C., Kopp, I., Neudorf, U., Niehues, T., Baus, H., Becker, M., Bertram, B., Dannecker, G., Deuter, C., Foeldvari, I., Frosch, M., Ganser, G., Gaubitz, M., Gerdes, G., Horneff, G., Illhardt, A., Mackensen, F., Minden, K., Pleyer, U., Schneider, M., Wagner, N., Zierhut, M.

“…Uveitis in juvenile idiopathic arthritis (JIA) is frequently associated with the development of complications and visual loss. Topical corticosteroids are the…”
Get full text

The German etanercept registry for treatment of juvenile idiopathic arthritis by Horneff, G, Schmeling, H, Biedermann, T, Foeldvari, I, Ganser, G, Girschick, H J, Hospach, T, Huppertz, H I, Keitzer, R, Küster, R M, Michels, H, Moebius, D, Rogalski, B, Thon, A

“…Objective: To describe a registry set up to monitor children treated with etanercept in Germany and Austria. Methods: Giannini’s criteria, duration of morning…”
Get full text

Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score by Foeldvari, I., Wierk, A.

“…Objectives. The modified Rodnan skin score (MRSS) is used as a primary outcome measure in most therapeutic trials in systemic sclerosis (SSc) in adults. Before…”
Get full text

Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis by Horneff, Gerd, Ebert, Annette, Fitter, Sigrid, Minden, Kirsten, Foeldvari, Ivan, Kümmerle-Deschner, Jasmin, Thon, Angelika, Girschick, Herrmann J., Weller, Frank, Huppertz, Hans I.

“…Objectives. Etanercept, a recombinant TNF receptor fusion protein, has been approved for the treatment of resistant polyarticular course juvenile idiopathic…”
Get full text

Growth and high resolution spectroscopic investigation of YAB:Tm crystal by Földvári, I., Beregi, E., Lengyel, K.

“…Tm-doped YAB single crystals were grown by the top-seeded flux technique. High resolution (0.04 cm −1) Fourier transform spectroscopy was employed to determine…”
Get full text

Current news from the BIKER register by Horneff, G, Minden, K, Foeldvari, I, Onken, N, Windschall, D, Hospach, A, Ganser, G, Klotsche, J, Becker, I

“…Innovative developments in the pharmacotherapy of juvenile idiopathic arthritis and especially biologics allow the formulation of new therapeutic targets, such…”
Get full text

A selective COX-2 inhibitor, meloxicam, as a treatment option in patients with juvenile idiopathic arthritis and gastrointestinal side effects from naproxen by Foeldvari, I

Get full text